EFTA02546529

From: Sent: To: Subject: Jeffrey Epstein <[email protected]> Friday, November 18, 2011 2:59 PM Re: I fully understand„ why don't you come and i won't mention i=. i just find it intellectually amusing, marving amd martin wi=l also be disappointed On Fri, Nov 18, 2=11 at 9:56 AM, George Church > > wrote: Yes. l'= working toward this goal fairly rapidly, but trying to do so in a way tha= minimizes risk to the field. James Wilson (who happened to be my physicia=, in the 1990s) set back the field of gene therapy by a decade by rushing.=u> http://www.scientifi=american.com/article.cfm?id=gene-therapy-an-interview <http://www.scientificamerican.com/article=cfm?id=gene-therapy-an-interview> My lab is good at conceivin= of radically new technologies as well as improving throughput and quality=by factors of ten. Given a couple of years and decent funding, this wou=d become much more reasonable. I'm too busy dong it well to get dis=racted by trying to do it badly. <=p> -- George <=p> From: Jeffrey =pstein (mailto:[email protected] <mailto:[email protected]> Sent: Friday, November 18, 2011 9:21 AM sorry, you can;t make it, . did the cloning is=sue , give you pause? communication is confidential, may =e attorney-client privileged, may constitute inside information, and is intended only for the use of the a=dressee. It is the property of =r>The information contained in this EFTA_R1_01700413 EFTA02546529 Jeffrey Epstein Unauthorized use, di=closure or copying of this communication or any part thereof is strict'= prohibited and may be unlawful. If you have received this communication in error, p=ease notify us immediately by return e-mail or by e-mail to [email protected], =nd destroy this communication and all copies thereof, including all attachm=nts. copyright -all rights reserved 2 EFTA_R1_01700414 EFTA02546530